Replies to post #40451 on OncoSec Medical Inc (ONCSQ)

[chickpea598]

I totally agree that Oncosec and Merck will later develop the combination therapy as a 1st line therapy but the quickest commercial opportunity right now is accelerated approval for checkpoint therapy failure population. I think it is an excellent strategy because success with the PISCES trial would be absolute proof of Oncosec's platform in combination with Keytruda....and shave years of waiting for an approval for validation. Once we get an FDA accelerated approval next year Merck will be all in and expand the pipeline with new trials for TNBC, NSCLC, Head and Neck cancer....etc. The future looks bright.....I gotta wear shades.

[akhsv777]

Hschlauch - thanks for share your valuable thoughts. I, along with many others, value your inputs. We're definitely looking good going forward.